Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 81151-81200 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05584670
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
291 participants
Started: Nov 29, 2022 · Completed: Nov 7, 2028
1 condition
1 sponsor
21 locations
NCT05640843
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
NA
Recruiting
150 participants
Started: Nov 29, 2022 · Completed: Nov 30, 2026
2 conditions
7 sponsors
8 locations
NCT04330846
Prospective Multicenter Randomized Comparative Study of the Treatment of de Novo Stenosis in Chron's Disease.
NA
Recruiting
40 participants
Started: Nov 29, 2022 · Completed: Apr 1, 2027
1 condition
1 sponsor
16 locations
NCT05645146
Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)
NA
Active, not recruiting
360 participants
Started: Nov 29, 2022 · Completed: Jan 31, 2028
3 conditions
2 sponsors
1 location
NCT04939935
Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
PHASE3
Recruiting
1,174 participants
Started: Nov 29, 2022 · Completed: May 31, 2027
1 condition
1 sponsor
40 locations
NCT05560113
Disrupting Fear-based Memory Consolidation
NA
Recruiting
66 participants
Started: Nov 28, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
2 locations
NCT05577754
Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP)
PHASE2
Recruiting
20 participants
Started: Nov 28, 2022 · Completed: Mar 31, 2027
1 condition
2 sponsors
13 locations
NCT06030349
Clinical Outcomes From Treatment and Evaluation of Obstructive Sleep Apnoea in Children With Down Syndrome
N/A
Recruiting
200 participants
Started: Nov 28, 2022 · Completed: Dec 28, 2027
5 conditions
6 sponsors
6 locations
NCT05562505
Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure
NA
Recruiting
140 participants
Started: Nov 28, 2022 · Completed: Jan 31, 2027
6 conditions
2 sponsors
7 locations
NCT05545150
Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study
PHASE2
Active, not recruiting
113 participants
Started: Nov 28, 2022 · Completed: Jul 1, 2026
6 conditions
2 sponsors
4 locations
NCT05565417
Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas
PHASE1/PHASE2
Active, not recruiting
67 participants
Started: Nov 28, 2022 · Completed: Jan 31, 2026
12 conditions
1 sponsor
9 locations
NCT05588167
Establishment of Genomic and Phenotypic Database for Niemann-Pick Disease, Type C
N/A
Recruiting
100 participants
Started: Nov 28, 2022 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT05659914
Olaparib and Durvalumab (MEDI4736) in Patients with Metastatic Pancreatic Cancer and DNA Damage Repair Genes Alterations
PHASE2
Active, not recruiting
40 participants
Started: Nov 28, 2022 · Completed: Jun 1, 2026
1 condition
2 sponsors
3 locations
NCT05728307
Post-market Observation of a Wireless Vital Sign Monitor for Hospitalized Newborns in Kenya
N/A
Recruiting
3,000 participants
Started: Nov 28, 2022 · Completed: Nov 30, 2023
2 conditions
3 sponsors
1 location
NCT05546658
Effects of Psilocybin in Obsessive Compulsive Disorder
EARLY_PHASE1
Recruiting
30 participants
Started: Nov 28, 2022 · Completed: Sep 12, 2027
1 condition
2 sponsors
1 location
NCT05428488
Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis
PHASE3
Recruiting
220 participants
Started: Nov 28, 2022 · Completed: Nov 30, 2027
1 condition
1 sponsor
17 locations
NCT05754658
African Cancer Genome: GMD
N/A
Recruiting
1,500 participants
Started: Nov 28, 2022 · Completed: Dec 31, 2025
2 conditions
14 sponsors
1 location
NCT05503225
Colchicine Use in Intracranial Atherosclerotic Disease
PHASE2
Recruiting
72 participants
Started: Nov 28, 2022 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT06217848
The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
EARLY_PHASE1
Recruiting
50 participants
Started: Nov 28, 2022 · Completed: Mar 8, 2024
3 conditions
1 sponsor
1 location
NCT05457010
Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS
PHASE1
Recruiting
24 participants
Started: Nov 28, 2022 · Completed: Nov 17, 2025
2 conditions
1 sponsor
5 locations
NCT05629585
A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)
PHASE3
Active, not recruiting
1,174 participants
Started: Nov 28, 2022 · Completed: Jan 30, 2030
1 condition
3 sponsors
276 locations
NCT05629065
Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)
NA
Active, not recruiting
800 participants
Started: Nov 28, 2022 · Completed: Jun 30, 2028
5 conditions
1 sponsor
1 location
NCT06355323
Bronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, France
NA
Recruiting
75 participants
Started: Nov 28, 2022 · Completed: Nov 28, 2025
4 conditions
1 sponsor
1 location
NCT06533137
"How Awareness and Subjectivity Modulate the Placebo Effect"
NA
Recruiting
84 participants
Started: Nov 28, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT06143969
Ultrasound-assisted, Catheter-directed Thrombolysis for Acute Intermediate-high-risk Pulmonary Embolism
N/A
Recruiting
180 participants
Started: Nov 28, 2022 · Completed: Mar 31, 2027
1 condition
1 sponsor
1 location
NCT05445856
Intraoperative Methadone for Postoperative Pain in Patients Undergoing Tonsillectomy
PHASE4
Recruiting
130 participants
Started: Nov 28, 2022 · Completed: Aug 31, 2024
1 condition
1 sponsor
1 location
NCT05768048
Long Term Trajectories of SMA Patients Receiving or Not Disease-modifying Treatments
N/A
Recruiting
500 participants
Started: Nov 28, 2022 · Completed: Nov 27, 2027
1 condition
5 sponsors
5 locations
NCT05865197
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF
N/A
Recruiting
20 participants
Started: Nov 28, 2022 · Completed: Sep 1, 2024
2 conditions
1 sponsor
1 location
NCT05470205
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
PHASE3
Recruiting
660 participants
Started: Nov 28, 2022 · Completed: Apr 30, 2026
2 conditions
4 sponsors
3 locations
NCT06514235
Image-guided Brachytherapy for Vaginal Cancer (EMBRAVE)
N/A
Recruiting
300 participants
Started: Nov 28, 2022 · Completed: Nov 30, 2033
1 condition
7 sponsors
1 location
NCT05179226
Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia
PHASE3
Recruiting
200 participants
Started: Nov 28, 2022 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT05729061
Analysis of Human Movement With Assistive Devices
NA
Recruiting
100 participants
Started: Nov 28, 2022 · Completed: Nov 28, 2024
4 conditions
2 sponsors
1 location
NCT05809414
Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis
PHASE3
Recruiting
144 participants
Started: Nov 28, 2022 · Completed: Feb 28, 2025
2 conditions
1 sponsor
4 locations
NCT04945681
Evaluating the Effectiveness of a Pneumococcal Immunisation Campaign in a Camp for Internally Displaced People
PHASE4
Active, not recruiting
2,882 participants
Started: Nov 27, 2022 · Completed: Feb 28, 2026
1 condition
4 sponsors
1 location
NCT05149625
Comparison of the Efficacy and Satisfaction of Blood Glucose Management Between Continuous Glucose Monitoring Versus Traditional Self-blood Glucose Measurement in Diabetic Patients After Pancreatectomy
NA
Recruiting
172 participants
Started: Nov 27, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06590883
The STatus Epilepticus Prognosis Study
N/A
Recruiting
50 participants
Started: Nov 27, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05340465
Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
PHASE2
Recruiting
120 participants
Started: Nov 27, 2022 · Completed: Dec 31, 2027
4 conditions
2 sponsors
1 location
NCT06005870
Zanubrutinib Combined With R-CHOP in the Treatment of Newly Diagnosed DLBCL With p53 Protein Expression
PHASE2
Recruiting
41 participants
Started: Nov 26, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT07139860
Artificial Intelligence System for Early Warning of Adverse Events in Acute Myocardial Infarction
N/A
Recruiting
1,400 participants
Started: Nov 26, 2022 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT04279158
Attention Modulation of Local and Global Inhibition Mechanisms
NA
Recruiting
120 participants
Started: Nov 26, 2022 · Completed: Nov 26, 2028
1 condition
1 sponsor
1 location
NCT05762029
Treatment of Extracorporeal Membrane Oxygenation in Severe Poisoning
N/A
Recruiting
60 participants
Started: Nov 26, 2022 · Completed: Nov 26, 2025
2 conditions
1 sponsor
1 location
NCT05552092
Optimal Depth for Esophageal Stethoscope
NA
Active, not recruiting
40 participants
Started: Nov 26, 2022 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT05569811
NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial
PHASE2
Active, not recruiting
120 participants
Started: Nov 25, 2022 · Completed: Jul 31, 2030
1 condition
2 sponsors
25 locations
NCT05644392
A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Treatment of Biliary Systemic Tumours
PHASE1
Recruiting
30 participants
Started: Nov 25, 2022 · Completed: Nov 25, 2025
1 condition
1 sponsor
1 location
NCT06785506
Multiple-biomarker Approach for Individualized Treatment of Heart Failure with Preserved Ejection Fraction
N/A
Recruiting
200 participants
Started: Nov 25, 2022 · Completed: Sep 1, 2026
3 conditions
6 sponsors
6 locations
NCT05469984
Comparing Two Prophylactic Antibiotic Protocols in Women With Term Prolonged Pre-labor Rupture of Membrane and Preterm Labor
NA
Recruiting
600 participants
Started: Nov 25, 2022 · Completed: Sep 26, 2025
2 conditions
1 sponsor
1 location
NCT05522881
The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan
N/A
Recruiting
410 participants
Started: Nov 25, 2022 · Completed: Dec 30, 2029
1 condition
7 sponsors
7 locations
NCT05428826
Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis
PHASE4
Recruiting
41 participants
Started: Nov 25, 2022 · Completed: Nov 25, 2028
1 condition
1 sponsor
15 locations
NCT05657054
Exercise Intervention Targeting Hip Strengthening Compared to Usual Care in Patients Undergoing Revision Hip Replacement
NA
Active, not recruiting
84 participants
Started: Nov 25, 2022 · Completed: Dec 1, 2027
1 condition
9 sponsors
9 locations
NCT06430047
Efficacy and Safety of EsoDuo®
PHASE4
Recruiting
180 participants
Started: Nov 25, 2022 · Completed: May 31, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
1621
1622
1623
1624
1625
1626
1627
More pages
2369
Next